Chris Daige

Identification of macrophage liver X receptors as inhibitors of atherosclerosis

Rajendra K. Tangirala, Eric D. Bischoff, Sean B. Joseph et al. · Proceedings of the National Academy of Sciences · 2002 · 436 citations · Full text

Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists

Eric D. Bischoff, Chris Daige, Diane Thomas et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 281 citations

Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression

Brandee Wagner, Annabel F. Valledor, Gang Shao et al. · Molecular and Cellular Biology · 2003 · 233 citations · Full text

Srebp1 Gene Expression, Genetics, Srebp1c Gene +20

Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)

Brenton Flatt, Richard Martin, Tielin Wang et al. · Journal of Medicinal Chemistry · 2009 · 161 citations · Full text

Chronic Administration, Molecular Biology, Farnesoid X Receptor +19

Non-redundant roles for LXR  and LXR  in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice

Eric D. Bischoff, Chris Daige, Mary Petrowski et al. · Journal of Lipid Research · 2010 · 94 citations

Inflammation, Metabolic Syndrome, Non-redundant Roles +12